官方服务：
资源简介：
Clinical Study Reports on Orlistat released by EMA
应用场景：
创建时间：
2016-06-09
相关数据集
Safety and efficacy of eblasakimab, an IL-13R alpha 1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a phase 1b, multiple-ascending dose study. Supplementary information.
This dataset contains figures, tables, and documents referenced in: Safety and efficacy of eblasakimab, an IL-13R alpha 1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: a ph
Mendeley Data2024-01-31 更新110
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumors
Aim: This first-in-human study evaluated safety and efficacy of CD40 agonist MEDI5083 with durvalumab in patients with advanced solid tumors. Methods: Patients received MEDI5083 (3–7.5 m
DataCite Commons2024-10-03 更新80
SUPPLEMENTAL INFORMATION Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: results from the JADE REGIMEN phase 3 trial
Supplemental material for Manuscript: Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate to severe atopic dermatitis: results from the JADE REGIMEN phase 3 trial (
Mendeley Data2021-07-01 更新00
Safety and tolerability of spesolimab in patients with ulcerative colitis
Interleukin (IL)-36 signaling has been shown to be increased in ulcerative colitis (UC). Spesolimab, a novel humanized monoclonal antibody, targets the IL-36 pathway. We report safety, immunogenicity,
DataCite Commons2023-03-15 更新80
Garcinia cambogia attenuates adipogenesis by affecting CEBPB and SQSTM1/p62-mediated selective autophagic degradation of KLF3 through RPS6KA1 and STAT3 suppression
The overexpansion of adipose tissues leads to obesity and eventually results in metabolic disorders. Garcinia cambogia ( G. cambogia ) has been used as an antiobesity supplement. However,
DataCite Commons2024-03-21 更新50
